Proteins |
|
|
|
BSA |
Polylactide-hyperbranched polyglycidol nanoparticles |
Nanoprecipitation |
[68,69] |
Insulin |
β-cyclodextrin labeled polyglycidol nanoparticles |
Coprecipitation |
[70] |
Insulin |
β-cyclodextrin labeled polyglycidol hydrogel |
Gelation |
[71] |
Asparaginase |
Nanogels from dendritic polyglycidols with azide and -p-propargyloxy-benzacetale |
Inverse nanoprecipitation |
[72] |
transglutaminase 1 |
Poly(N-isopropylacrylamide)-polyglycerol-based nanogels |
Nanogel swelling in protein solution |
[73] |
Nucleic acids |
|
|
|
DNA |
Quarternized a poly(glycidol-co-ethylene oxide) |
Nanoprecipitation |
[74] |
pDNA |
Quarternized branched poly(glycidol-co-2,3-epoxypropyldiethyl-amine) and DNA polyplexes |
Incubation of polymer and nucleic acid solution |
[75] |
siRNA |
Polyplexes of corona aminated hyperbranched polyglycidol and siRNA |
Incubation of polymer and nucleic acid solution |
[76] |
siRNA |
Polyplexes of hyperbranched polyglycidol modified with glycine and siRNA |
Incubation of polymer and nucleic acid solution |
[77] |
siRNA |
Polyplexes of amphiphilic copolymer containing hyperbranched polyglycidol end-capped with amines and siRNA |
Incubation of polymer and nucleic acid solution |
[78] |
pDNA |
Polyplexes of adamantane-modified hyperbranched polyglycerol end-capped with cationic β-cyclodextrin and pDNA |
Incubation of polymer and nucleic acid solution |
[79] |
pDNA |
Polyplexes of polyglycidol-pluronic-poly-glycidol with 2-(N,N-dimethylaminomethyl)-5-aminomethyl phenylboronic acid groups and pDNA |
Incubation of polymer and nucleic acid solution |
[80] |
pDNA |
Polyplexes of poly(ethylene oxide)-(branched polyglycidol) with endgroups capped with tris(2-aminoethyl)amine) |
Incubation of polymer and nucleic acid solution |
[81] |
pDNA |
nanodiamond particles with immobilized polyglycidol modified with grafted poly(arg-co-lys-co-his) |
Incubation of nanocarrier and nucleic acid solution |
[82] |
pDNA and doxorubicin hydrochloride |
Vesicles composed of cyclodextrin labeled with branched polyglycidol end-capped with tris(2-aminoethyl)amine) and bearing aliphatic chains |
Nanoprecipitation |
[83] |
DNA Lamin A/C) and 5′-CTGGACTTCCAGAAGAACATT-3−
|
Polyplexes of hyperbranched polyglycidol modified by addition of oligoamines via the photo-cleavable linkages |
Incubation of polymer and nucleic acid solution |
[84] |
Anticancer drugs |
|
|
|
Doxorubicin |
Hyperbranched polyglycidol |
Covalent immobilization via the enzymatically cleavable linkage |
[85] |
Doxorubicin |
Hyperbranched polyglycidol with grafted poly(ethylene oxide) |
Covalent immobilization via the enzymatically cleavable linkage |
[86] |
Doxorubicin |
Poly(ethylene oxide)-[hyperbranched polyglycidol] |
Covalent immobilization via pH sensitive hydrazone linkage |
[87] |
Doxorubicin |
Hyperbranched polyglycidol with grafted poly(ethylene oxide) and targeting antibodies agains epidermal growth factor |
Covalent immobilization via pH sensitive hydrazone linkage |
[88] |
Doxorubicin, indodicarbocyanine dye |
Hyperbranched polyglycidol |
Covalent immobilization of drug and dye via cleavable linkage. Monitoring of drug release by fluorescence |
[89] |
Doxorubicin |
Nanodiamond particles with grafted hyperbranched polyglycidol end-capped with RGD tripeptide |
Covalent immobilization via pH sensitive hydrazone linkage |
[90] |
Cisplatin |
Hyperbranched polyglycidol modified with succinic anhydride |
Covalent immobilization via carboxyl groups |
[91] |
Cisplatin |
Nanodiamond particles with grafted hyperbranched polyglycidol end-capped with RGD tripeptide and COOH groups |
Covalent immobilization via carboxyl groups |
[92] |
Methotrexate |
Fe3O4 nanoparticles with immobilized hyperbranched polyglycidol |
Covalent immobilization via pH sensitive hydrazone linkage |
[93] |
Paclitaxel |
Hyperbranched polyglycidol with sulfate and amine end groups |
Covalent immobilization via cleavable ester linkage |
[94] |
Paclitaxel |
Hyperbranched polyglycidol with attached poly(ethylene oxide) and alkyl chains |
Solubilization of hydrophobic drug |
[95,96] |
Paclitaxel |
Polymeric micelles of hyperbranched polyglycidol labeled with β-cyclodextrin |
Nanoprecipitation |
[97] |
Docetaxel |
Hyperbranched polyglycidol with attached poly(ethylene oxide) and alkyl chains |
Solubilization of hydrophobic drug |
[96] |
Docetaxel |
Hyperbranched polyglycidol with attached alkyl chains |
Nanoprecipitation |
[98] |
Sagopilone |
Hyperbranched polyglycidol with attached alkyl chains |
Entrapment during micellization |
[99] |
Miscellaneous |
|
|
|
Nimodipine |
Hyperbranched polyglycidol with biphenyl groups in the core |
Solubilization of hydrophobic drug |
[100] |
Quercetin |
Polylactide-(hyperbranched polyglycidol) |
Nanoprecipitation |
[101] |
Endomorphins |
Hyperbrached polyglycidol modified by addition of poly(lactide-co-glycolide) chains |
Water-in oil-in water double emulsification |
[102] |